Article
AR Signaling and the PI3K Pathway in Prostate Cancer
15 Apr 2017
Abstract excerpt
Prostate cancer is a leading cause of cancer-related death in men worldwide. Aberrant signaling in the androgen pathway is critical in the development and progression of prostate cancer. Despite ongoing reliance on androgen receptor (AR) signaling in castrate resistant disease, in addition to the development of potent androgen targeting drugs, patients invariably develop treatment resistance. Interactions between...
Topics
Join the communities discussing this publication.
